Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT/R: Clopidogrel and Prasugrel PK/PD in HIV Patients
NCT03054207Phase 1Terminated
- Start
- Jun 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of clopidogrel and prasugrel (4 arms). Primary endpoint: Platelet Reactivity Index. Started Jun 2015; status: terminated.
02
Drugs
clopidogrelprasugrel
Beyond the preview
Go deeper on NCT03054207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03054207.